Xenetic Biosciences, Inc. (XBIO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$6.34M2013: -$8.61M2014: -$12.92M2015: -$9.82M2016: -$47.43M2017: -$3.57M2018: -$7.28M2019: -$12.89M2020: -$13.94M2021: -$5.75M2022: -$6.72M2023: -$4.52M2024: -$4.20M2025: -$2.83M-$2.83M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$2.83M+32.6%
2024-$4.20M+6.9%
2023-$4.52M+32.8%
2022-$6.72M-16.9%
2021-$5.75M+58.8%
2020-$13.94M-8.2%
2019-$12.89M-77.1%
2018-$7.28M-103.9%
2017-$3.57M+92.5%
2016-$47.43M-382.9%
2015-$9.82M+24.0%
2014-$12.92M-50.1%
2013-$8.61M-35.8%
2012-$6.34M